文献速递临床微生物分子诊断

T2Candida 快速真菌检测 panel 在学术医疗中心识别念珠菌血症的评估

Evaluation of a Rapid Fungal Detection Panel for Identification of Candidemia at an Academic Medical Center.
PubMed 文献 · J Clin Microbiol · 2020-02-24

该研究回顾性分析了 2017 年 2 月至 2018 年 3 月期间同时采集 T2Candida panel 和真菌血培养的 433 对样本,念珠菌血症验前概率为 4.4%。T2Candida panel 的敏感性和特异性分别为 64.7% 和 95.6%,阳性预测值和阴性预测值分别为 40.7% 和 98.5%。研究表明该 panel 特异性高,但敏感性和阳性预测值在临床实践中可能低于既往报道,应作为血培养的辅助手段。

要点

  • T2Candida panel 敏感性 64.7%、特异性 95.6%,阳性预测值仅 40.7%。
  • 阴性预测值达 98.5%,阴性结果有助于排除念珠菌血症。
  • 应作为血培养的辅助手段,而非替代,用于念珠菌血症诊断。

核心结论

  • T2Candida panel 是高度特异的诊断工具,但敏感性和阳性预测值在临床实践中可能低于既往报道。
  • 临床医生应将此 panel 作为血培养的辅助手段来做出念珠菌血症的明确诊断。

研究设计与样本

  • 回顾性图表审查,纳入 2017 年 2 月至 2018 年 3 月住院期间同时采集 T2Candida panel 和真菌血培养的患者。
  • 共识别 433 对 T2Candida panel 与真菌血培养配对样本。
  • 主要结局为 panel 对比真菌血培养的敏感性、特异性、阳性预测值和阴性预测值。

主要发现

  • 念珠菌血症验前概率为 4.4%。
  • 敏感性 64.7%,特异性 95.6%,阳性预测值 40.7%,阴性预测值 98.5%。
  • 16 例患者 T2Candida panel 阳性而真菌血培养阴性,6 例患者 panel 阴性而真菌血培养阳性。
  • 实施 T2Candida panel 后总体抗真菌 DOT/1000 患者日改善,但 panel 移除后米卡芬净使用继续下降。

关键数值与推荐

  • 敏感性 64.7%,特异性 95.6%,阳性预测值 40.7%,阴性预测值 98.5%(对比真菌血培养)。
  • 验前概率 4.4%。
  • 不一致结果:panel 阳性/培养阴性 16 例,panel 阴性/培养阳性 6 例。

临床怎么用

  • 可将 T2Candida panel 作为血培养的辅助手段用于念珠菌血症诊断。
  • 阴性预测值较高,阴性结果对排除念珠菌血症有参考价值。
  • 阳性结果需结合血培养和临床情况综合判断,因阳性预测值较低。

局限性

  • 为单中心回顾性图表审查。
  • 念珠菌血症验前概率较低(4.4%),可能影响阳性预测值。
  • 原文未报告其他局限性信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This study was conducted to assess the utility of the T2Candida panel across an academic health center and identify potential areas for diagnostic optimization. A retrospective chart review was conducted on patients with a T2Candida panel and mycolytic/fungal (myco/f lytic) blood culture collected simultaneously during hospitalizations from February 2017 to March 2018. The primary outcome of this study was to determine the sensitivity, specificity, and positive and negative predictive values of the panel compared to myco/f lytic blood culture. Secondary outcomes included Candida species isolated from culture or detected on the panel, source of infection, days of therapy (DOT) of antifungals in patients with discordant results, and overall antifungal DOT/1,000 patient days. A total of 433 paired T2Candida panel and myco/f lytic blood cultures were identified. The pretest likelihood of candidemia was 4.4%. The sensitivity and specificity were 64.7% and 95.6%, respectively. The positive and negative predictive values were 40.7% and 98.5%, respectively. There were 16 patients with T2Candida panel positive and myco/f lytic blood culture negative results, while 6 patients had T2Candida panel negative and myco/f blood culture positive results. The overall antifungal DOT/1,000 patient days was improved after implementation of the T2Candida panel; however, the use of micafungin continued to decline after the panel was removed. We found that the T2Candida panel is a highly specific diagnostic tool; however, the sensitivity and positive predictive value may be lower than previously reported when employed in clinical practice. Clinicians should use this panel as an adjunct to blood cultures when making a definitive diagnosis of candidemia.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Bomkamp JP, Sulaiman R, Hartwell JL, et al. Evaluation of a Rapid Fungal Detection Panel for Identification of Candidemia at an Academic Medical Center. J Clin Microbiol. 2020. PMID: 31852762. doi:10.1128/JCM.01408-19

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。